We are live on ! Find out more
MESO

Mesoblast

43 hedge funds and large institutions have $32.1M invested in Mesoblast in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

189% more capital invested

Capital invested by funds: $11.1M → $32.1M (+$21M)

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

26% more funds holding

Funds holding: 3443 (+9)

0.02% more ownership

Funds ownership: 0.23%0.25% (+0.02%)

95% less call options, than puts

Call options by funds: $829K | Put options by funds: $16.3M

Holders
43
Holders Change
+9
Holders Change %
+26.47%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
14
Reduced
8
Closed
6
Calls
$829K
Puts
$16.3M
Net Calls
-$15.5M
Net Calls Change
-$15.2M

MESO Hedge Fund Activity: Q2 2020 in Review

43 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2020, worth a combined $32.1M — up 189% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new MESO positions and 6 closed out — a net gain of 9 holders — while 14 added to existing stakes and 8 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.18M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $931K sold.

  • 43 institutional investors held Mesoblast (MESO) as of Q2 2020, up from 34 in Q1 2020.
  • Funds reported $32.1M of Mesoblast stock for Q2 2020, up 189% quarter-over-quarter.
  • 15 funds opened new Mesoblast positions in Q2 2020 and 6 closed out, a net change of +9 holders.
  • The largest Mesoblast buyer in Q2 2020 was Goldman Sachs, an estimated $2.18M added.
  • The largest Mesoblast seller in Q2 2020 was Renaissance Technologies, an estimated $931K sold.

Based on aggregated 13F filings for Q2 2020.